Herantis Pharma’s financial year is the calendar year. During the year, the company publishes an Annual Financial Statements Release and one Interim Report related to accounting period’s first six months. The Financial Statements and Interim Reports will be released around at 9.00 a.m. (Finnish time) on the given dates.
|30 Jul – 28 Aug 2018||Silent period|
|30 Jul – 28 Aug 2018||Closed window period|
|29 Aug 2018||Interim report release on January-June 2018|
|30 Aug 2018||Herantis Pharma presentation at the Lsx Nordic conference in Stockholm|
|5-6 Sep 2018||Meet Herantis Pharma at BioPharm America in Boston|
|11-12 Sep 2018||Meet Herantis Pharma at NLS Days in Stockholm|
|20 Sep 2018||Herantis Pharma presentation at Sijoittaja 2018 event in Helsinki|
|4-5 Oct 2018||Herantis Pharma presentation at the 18th Annual Biotech in Europe Forum in Basel|
|5-7 Nov 2018||Meet Herantis Pharma at BioEurope in Copenhagen|
During the Closed window period, trading of Herantis Pharma shares or derivatives is forbidden for the Insider group.